RMEBX
Price
$63.09
Change
+$0.35 (+0.56%)
Updated
Jun 12 closing price
Net Assets
116.64B
TGDIX
Price
$16.84
Change
+$0.14 (+0.84%)
Updated
Jun 12 closing price
Net Assets
555.71M
Interact to see
Advertisement

RMEBX vs TGDIX

Header iconRMEBX vs TGDIX Comparison
Open Charts RMEBX vs TGDIXBanner chart's image
RMEBX vs TGDIX Comparison Chart in %
View a ticker or compare two or three
VS
RMEBX vs. TGDIX commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and TGDIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 117B vs. TGDIX (556M). TGDIX (1.05) and RMEBX (1.04) have matching dividends . RMEBX was incepted earlier than TGDIX: RMEBX (12 years) vs TGDIX (22 years). RMEBX (1.07) is less costly to investors than TGDIX (0.72). TGDIX is a more actively managed with annual turnover of: 61.97 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than TGDIX: RMEBX (250) vs TGDIX (2000). RMEBX annual gain was more profitable for investors over the last year : 9.16 vs. TGDIX (5.17). RMEBX return over 5 years is better than : 33.79 vs. TGDIX (19.08).
RMEBXTGDIXRMEBX / TGDIX
Total Expense Ratio1.070.70153%
Annual Report Gross Expense Ratio1.070.72149%
Fund Existence12 years22 years-
Gain YTD6.88512.08157%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets117B556M21,043%
Annual Yield % from dividends1.041.0599%
Returns for 1 year9.165.17177%
Returns for 3 years33.9729.78114%
Returns for 5 years33.7919.08177%
Returns for 10 years92.81-9.16-1,014%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGHT1.780.05
+3.18%
8x8
NPKI14.980.33
+2.25%
NPK International Inc
SPOT482.00-4.00
-0.82%
Spotify Technology SA
GOLF98.16-1.28
-1.29%
Acushnet Holdings Corp
TVRD2.64-0.07
-2.58%
Tvardi Therapeutics Inc